对AF-04的功能性特征,这是一个afucosylated抗MARVGP抗体
Min Zhang1, Yuting Zhang2, Haiyan Wu1
1State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Beijing 100089, China.
Biochimica et biophysica acta. Molecular basis of disease
|November 23, 2023
概括
一种新的糖基工程单克隆抗体,AF-04,显示了增强的马堡病毒 (MARV) 中和. 化增强了抗体依赖的细胞中介细胞毒性 (ADCC),为MARV感染提供了一个有前途的新疗法.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 马尔堡病毒 (MARV) 导致严重的出血热,死亡率高.
- 目前,对于MARV感染,还没有有效的治疗或预防措施.
- 单克隆抗体 (mAbs) 显示出MARV治疗的潜力,ADCC等免疫效应因子功能对体内疗效至关重要.
研究的目的:
- 开发和评估一种具有增强马尔堡病毒GP特异性活性的糖基工程 mAb.
- 调查afucosylation对mAb结合亲和力和效应器功能的影响.
主要方法:
- 通过使用糖基工程,生成一种MARV GP特定的fucose-knockout mAb (AF-04).
- 将AF-04与FcγRIIIa的结合亲和力与其父 mAb (AF-03) 的结合亲和力进行比较.
- 对FcγRIIIa.a下游的NK细胞激活和NFAT信号的评估.
主要成果:
- 与AF-03相比,AF-04的afucosylation显著增加了其与多态FcγRIIIa (F176/V176) 的结合亲和力.
- AF-04在效应细胞中表现出增强的NK细胞激活和NFAT表达.
- 增强的结合和效应器功能表明改善了治疗潜力.
结论:
- AF-04,一种糖基工程 mAb,表现出强大的MARV特异性活性.
- 亚福化是一种可行的策略,可以增强对MARV的mAb介导ADCC.
- AF-04代表了对马尔堡病毒病的有希望的新疗法候选者.
关键词:
ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC ADCC is also known as ADCC ADCC ADCC is also known as ADCC在Fucose的淘汰赛中.甘油的工程学是什么?马尔堡病毒 (MARV) 是一种一个单克隆抗体的抗体.更多相关视频
09:06Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
Published on: December 23, 2016
21.0K
13:21Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
15.8K
